Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells

Infection and Immunity

Volumn 77, Issue 6, 2009, Pages 2330-2342

  Banerjee, Subha ^a   Ghosh, June ^a   Sen, Subha ^a   Guha, Rajan ^a   Dhar, Ranjan ^a   Ghosh, Moumita ^a   Datta, Sanchita ^a   Raychaudhury, Bikramjit ^a   Naskar, Kshudiram ^a   Haldar, Arun Kumar ^a   Lal, C S ^b   Pandey, K ^b   Das, V N R ^b   Das, Pradeep ^b   Roy, Syamal ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLEST 4 EN 3 ONE; CHOLESTEROL; GAMMA INTERFERON; IMMUNOGLOBULIN G2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 4; LIPOSOME; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL MEMBRANE FLUIDITY; CELLULAR IMMUNITY; CONTROLLED STUDY; LEISHMANIA DONOVANI; MACROPHAGE; NONHUMAN; PARASITE CULTIVATION; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; TH1 CELL; VISCERAL LEISHMANIASIS; ANIMAL; CELL MEMBRANE; CHEMISTRY; DRUG EFFECT; HAMSTER; IMMUNOLOGY; LEISHMANIA; MEMBRANE FLUIDITY; METABOLISM; SECRETION;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL MEMBRANE; CHOLESTEROL; CRICETINAE; CYTOKINES; LEISHMANIA; LEISHMANIASIS, VISCERAL; LIPOSOMES; MACROPHAGES; MEMBRANE FLUIDITY; NITRIC OXIDE; REACTIVE OXYGEN SPECIES;

EID: 66549085866     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00057-09     Document Type: Article

References (69)

1. Amer, A. O., and M. S. Swanson. 2002. Phagosome of one's own: a microbial guide to life in the macrophage. Curr. Opin. Microbiol. 5:56-61.
2. Amundson, D. M., and M. Zhou. 1999. Fluorometric method for the enzymatic determination of cholesterol. J. Biochem. Biophy. Methods 38:43-52.
3. Anderson, F. C., R. Lira, S. Kamhawi, Y. Belkaid, T. A. Wynn, and D. Sacks. 2008. Il-10 and TGF-β control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL/6 mice. J. Immunol. 180:4090-4097.
4. Anderson, H. A., E. M. Hiltbold, and P. A. Roche. 2000. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat. Immunol. 1:156-162.
5. Banerjee, A., M. De, and N. Ali. 2008. Complete cure of experimental visceral leishmanisis with amphotericin B in stearylamine-bearing cationic liposomes involves down-regulation of IL-10 and favourable T cell responses. J. Immunol. 181:1386-1398.
6. Basu, R., S. Bhaumik, J. M. Basu, K. Naskar, T. De, and S. Roy. 2005. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis. J. Immunol. 174:7160-7171.
7. Basu, R., S. Roy, and P. Walden. 2007. HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages. J. Infect. Dis. 195:1373-1380.
8. Bograh, A., R. Carpentier, and H. A. Tajmir-Riahi. 1999. The effect of cholesterol on the solution structure of proteins of photosystem II. Protein secondary structure and photosynthetic oxygen evolution. J. Colloid Interface Sci. 210:118-122.
9. Burger, K., G. Gimpl, and F. Farenholz. 2000. Regulation of receptor function by cholesterol. Cell. Mol. Life Sci. 57:1577-1592.
10. Chakraborty, D., S. Banerjee, A. Sen, K. K. Banerjee, P. Das, and S. Roy. 2005. Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts. J. Immunol. 175:3214-3224.
11. Chappuis, F., S. Sundar, A. Hailu, H. Galib, S. Rijal, R. W. Peeling, J. Alvar, and M. Boelaert. 2007. Visceral leishmaniasis: what are needed for diagnosis, treatment and control? Nat. Rev. Microbiol. 5:S7-S16.
12. Chen, C. L., I. H. Liu, S. J. Fliesler, X. Han, S. S. Huang, and J. S. Huang. 2007. Cholesterol suppresses cellular TGF-β responsiveness: implications in atherogenesis. J. Cell Sci. 120:3509-3521. (Pubitemid 350120944)
13. Chow, D. D., H. E. Essien, M. M. Padki, and K. J. Hwang. 1989. Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect. J. Pharmacol. Exp. Ther. 248:506-513.
14. Croft, S. L., S. Sundar, and A. H. Fairlamb. 2006. Drug resistance in leishmaniasis. Clin. Microbiol. Rev. 19:111-126.
15. Dabrowski, M. P., W. E. Peel, and A. E. R. Thomson. 1980. Plasma membrane cholesterol regulates human lymphocyte cytotoxic function. Eur. J. Immunol. 10:821-827.
16. Elias, E. R., M. B. Irons, A. D. Hurley, G. S. Tint, and G. Salen. 1997. Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS). Am. J. Med. Genet. 68:305-310.
17. Fielding, R. M., L. Moon-McDermott, R. O Lewis, and M. J. Horner. 1999. Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey. Antimicrob. Agents Chemother. 43:503-509.
18. Fuertes, M. A., C. Berherich, R. M. Lozano, G. Gimenez-Gallego, and C. Alonso. 1999. Folding stability of the kinetoplastid membrane protein-11 (KMP-11) from Leishmania infantum. Eur. J. Biochem. 260:559-567.
19. Gabizon, A., and D. Papahadjopoulos. 1988. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA 85:6949-6953.
20. Ghalib, H. W., M. R. Piuvezam, Y. A. Skeiky, M. Siddig, F. A. Hashim, A. M. el-Hassan, D. M. Russo, and S. G. Reed. 1993. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Investig. 92:324-329.
21. Ghosh, M., C. Pal, M. Ray, S. Maitra, L. Mandal, and S. Bandyopadhyay. 2003. Dendritic cell-based immunotherapy combined with antimony-based chemotherapy cures established murine visceral leishmaniasis. J. Immunol. 170:5625-5629. (Pubitemid 36617853)
22. 15N] nitrate in biological fluids. Anal. Biochem. 126:131-138.
23. Griffith, J. M., and G. Posthuma. 2002. A reliable and convenient method to store ultrathin thawed cryosections prior to immunolabeling. J. Histochem. Cytochem. 50:57-62.
24. Harikumar, K. G., V. Puri, R. Singh, K. Hanada, R. E. Pagano, and L. J. Miller. 2005. Differential effects of modification of membrane cholesterol and sphingolipids on the conformation, function and trafficking of the G protein-coupled cholecystokinin receptor. J. Biol. Chem. 280:2176-2185.
25. Hughes, D. A., P. J. Townsend, and P. L. Haslam. 1992. Enhancement of antigen presenting function of monocytes by cholesterol: possible relevance to inflammatory mechanisms in extrinsic allergic alveolitis and atherosclerosis. Clin. Exp. Immunol. 87:279-286.
26. Humphries, G. M. K., and H. M. McConnell. 1977. Membrane-controlled depletion of complement activity by spin-label-specific IgM. Proc. Natl. Acad. Sci. USA 74:3537-3541.
27. Kalipatnapu, S., and A. Chattopadhyay. 2007. Membrane organization of the serotonin 1A receptor monitored by a detergent-free approach. J. Cell. Mol. Neurobiol. 27:463-474.
28. Kaye, P. M., M. Svensson, M. Ato, A. Maroof, R. Polley, S. Stager, S. Zubairi, and C. R. Engwerda. 2004. The immunopathology of experimental visceral leishmaniasis. Immunol. Rev. 201:239-253.
29. Keithly, J. S. 1976. Infectivity of Leishmania donovani amastigotes and promastigotes for golden hamsters. J. Protozool. 23:244-245.
30. + T cells. Eur. J. Immunol. 26:3163-3169.
31. + T-cells. J. Immunol. 159:1828-1834.
32. Kirby, C., J. Clarke, and G. Gregoriadis. 1980. Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem. J. 186:591-598.
33. Lal, C. S., A. Kumar, S. Kumar, K. Panday, N. Kumar, S. Bimal, P. K. Sinha, and P. Das. 2007. Hypocholesterolemia and increased triglyceride in paediatric visceral leishmaniasis. Clin. Chim. Acta 382:151-153.
34. Lee, Y. J., Y. Han, H T. Lu, V. Nguyen, H. Qin, P. H. Howe, B. A. Hocevar, J. M. Boss, R. M. Ransohoff, and E. N. Benveniste. 1997. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J. Immunol. 158:2065-2075. (Pubitemid 127469987)
35. Liew, F. Y., Y. Li, and S. Millott. 1990. Tumour necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145:4306-4310.
36. Liew, F. Y., Y. Li., and S. Millott. 1990. Tumour necrosis factor (TNF-α) in leishmaniasis. II. TNF-α-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine. Immunology 71:556-559.
37. Lowry, O. H., N. J. Rosebrough, A. L Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
38. + T-cells in a retrovirus-induced immunodeficiency syndrome, murine AIDS. J. Immunol. 149:1707-1713.
39. Marcum, J. M., J. R. Dedman, B. R. Brinkley, and A. R. Means. 1978. Control of microtubule assembly-disassembly by calcium-dependent regulator protein. Proc. Natl. Acad. Sci. USA 75:3771-3775.
40. Medda, S., N. Das, B. K. Bachhawat, S. B. Mahato, and M. K. Basu. 1990. Targeting of plant glycoside-bearing liposomes to specific cellular and subcellular sites. Biotechnol. Appl. Biochem. 12:537-543.
41. Meier, C. L., M. Svensson, and P. M. Kaye. 2003. Leishmania-induced inhibition of macrophage antigen presentation analyzed at the single-cell level. J. Immunol. 171:6706-6713.
42. Melby, P. C., V. V. Tryon, B. Chandrasekar, and G. L. Freeman. 1998. Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis. Infect. Immun. 66:2135-2142.
43. 2+ levels through the activation of non-selective cation channels induced by oxidative stress causes mitochondrial depolarization leading to apoptosis-like death in Leishmania donovani promastigotes. J. Biol. Chem. 277:24717-24727.
44. Mukhopadhyay, S., P. Sen, S. Bhattacharyya, S. Majumdar, and S. Roy. 1999. Immunoprophylaxis and immunotherapy against experimental visceral leishmaniasis. Vaccine 17:291-300. (Pubitemid 28552790)
45. Muller, C. P., D. A. Stephany, M. Shinitzky, and J. R. Wunderlich. 1983. Changes in cell surface expression of MHC and Thy 1.2 determinants following treatment with lipid modulating agents. J. Immunol. 131:1356-1362.
46. Nelles, M. J., W. R. Duncan, and J. W. Streilein. 1981. Immune response to acute virus infection in the syrian hamster. II. Studies on the identity of virus induced cytotoxic effector cells. J. Immunol. 126:214-218.
47. Neogy, A. B., A. Nandy, B. G. Dastidar, and A. B. Chowdhury. 1988. Modulation of the cell-mediated immune response in kala-azar and post-kalaazar dermal leishmaniasis in relation to chemotherapy. Ann. Trop. Med. Parasitol. 82:27-34.
48. Perez-Guzman, C., M. H. Vargas, F. Quinonez, N. Bazavilvazo, and A. Aguilar. 2005. A cholesterol-rich diet accelerates bacteriological sterilization in pulmonary tuberculosis. Chest 127:643-651. (Pubitemid 40229329)
49. Peters, B. A., M. Sothmann, and W. B. Wehrenberg. 1989. Blood leukocyte and spleen lymphocyte immune response in chronically physically active and sedentary hamsters. Life Sci. 45:2239-2245. (Pubitemid 20003069)
50. Pucadyil, T. J., and A. Chattopadhyay. 2007. Cholesterol: a potent therapeutic target in Leishmania infection? Trends Parasitol. 23:49-53.
51. Radhakrishnan, A., and H. M. McConnell. 2000. Chemical activity of cholesterol in membranes. Biochemistry 39:8119-8124. (Pubitemid 30460960)
52. Razzaq, T. M., P. Ozebge, E. C. Jury, P. Sembi, N. M. Blackwell, and P. S. Kabouridis. 2004. Regulation of T-cell receptor signaling by membrane microdomain. Immunology 113:413-426. (Pubitemid 39593360)
53. Rooijen, N. V., and A. Sanders. 1998. The macrophage as target or obstacle in liposome based target strategies. Int. J. Pharm. 162:45-50.
54. Roy, S., G. Terres, and S. Leskowitz. 1987. The azobenzenearsonate conjugate of poly-glutamic-lysine-tyrosine will induce tyrosine- azobenzenearsonate-specific T-cell responses and clones in nonresponder mice. Cell. Immunol. 105:118-126.
55. Roychoudhury, K., B. Dasgupta, P. Sen, T. Laskay, W. Solbach, T. De, and S. Roy. 2006. Evidence of direct interactions between the CC-chemokines CCL3, CCL4 and CCL5 and Leishmania promastigotes. Mol. Biochem. Parasitol. 150:374-377.
56. Saha, B., D. Bandyopadhyay, and S. Roy. 1995. Immunobiological studies on experimental visceral leishmaniasis. IV. Kinetics of evolution of disease promoting versus host protective cells of monocytes, macrophage lineage and their characterization. Scan. J. Immunol. 42:540-546.
57. Saha, B., H. N. Roy, A. Pakrashi, R. N. Chakrabarti, and S. Roy. 1991. Immunobiological studies on experimental visceral leishmaniasis. I. Changes in lymphoid organs and their possible role in pathogenesis. Eur. J. Immunol. 21:577-581.
58. Silvestre, R., A. Cordeiro-Da-Silva, N. Santarem, B. Vergnes, D. Sereno, and A. Ouaissi. 2007. SIR2-deficient Leishmania infantum induces a defined IFN-γ/IL-10 pattern that correlates with protection. J. Immunol. 179:3161-3170.
59. Simons, K., and E. Ikonen. 2000. How cells handle cholesterol. Science 290:1721-1726. (Pubitemid 32004797)
60. Slotte, J. P., and B. Lundberg. 1983. Effects of cholesterol surface transfer on cholesterol and phosphatidyl choline synthesis in cultured rat arterial smooth muscle cells. Med. Biol. 61:223-227.
61. Stauber, L. A. 1958. Host resistance to the Khartoun strain of Leishmania donovani. Rice Inst. Pam. 45:80-96.
62. Stevens, T. L., A. Bossie, V. M. Sanders, R. Fernandez-Botran, R. L. Coffman, T. R. Mosmann, and E. S. Vitetta. 1988. Regulation of antibody isotype secretion by subsets of antigen specific T-helper cells. Nature 334:255-258. (Pubitemid 18173376)
63. Sundar, S., T. K. Jha, C. P. Thakur, P. K. Sinha, and S. K. Bhattacharya. 2007. Injectable paramomycin for visceral leishmaniasis in India. N. Engl. J. Med. 356:2571-2581.
64. van der Goot, F. G., and T. Harder. 2001. Raft membrane domains: from a liquid ordered membrane phase to a site of pathogen attack. Semin. Immunol. 13:89-97.
65. Watkins, D. I., Z. W. Chen, A. L. Hughes, A. Lagos, A. M Lewis, Jr., J. A. Shadduck, and N. L. Letvin. 1990. Syrian hamsters express diverse MHC class I gene products. J. Immunol. 145:3483-3490.
66. Wilson, M. E., B. M. Young, B. L. Davidson, K. A. Mante, and S. E. McGowan. 1998. The importance of TGF-β in murine visceral leishmaniasis. J. Immunol. 161:6148-6155. (Pubitemid 28535987)
67. World Health Organization. 2006. Control of leishmaniasis. Report by the Secretariat. World Health Organization, Geneva, Switzerland.
68. Wunder, C., Y. Churin, F. Winau, D. Warnecke, M. Vieth, B. Lindner, U. Zahringer, H.-J. Mollenkopf, E. Heinz, and T. F. Meyer. 2006. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat. Med. 12:1030-1038.
69. Zerpa, O., M. Ulrich, M. Polegre, A. Avila, O. N. Matos, I. Mendoza, F. Pratlong, C. Ravel, and J. Convit. 2007. Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses. Br. J. Dermatol. 156:1328-1335.